Patient characteristics | |
---|---|
Number of eligible patients | 42 |
Age, median (IQR), year | 59.4 (47.9–69.2) |
Sex, no. (%) | |
Male | 27 (64) |
Female | 15 (35) |
Weight, median (IQR), kg | 74.0 (65.0–88.5) |
Body mass index, median (IQR), kg/m2 | 25.6 (21.8–30.8) |
Obesity (BMI ≥ 30), no. (%) | 11 (27) |
Comorbidities, no. (%) | |
Diabetes | 8 (19) |
Chronic obstructive pulmonary disease | 4 (9) |
Immuno-incompetence | 13 (31) |
Cardiac failure | 8 (19) |
Liver failure | 15 (35) |
End-stage renal disease | 3 (7) |
Home oxygen/ventilation | 1 (2) |
Location before ICU admission, no. (%) | |
Other hospital ward | 19 (45) |
Emergency room | 15 (35) |
Other ICU | 8 (19) |
Reason for ICU admission, no. (%) | |
Cardiovascular/respiratory (e.g. cardiogenic, septic-shock) | 35 (83) |
Liver failure | 7 (16) |
Surgical status at ICU admission, no. (%) | |
Scheduled surgery | 1 (2) |
Emergency surgery | 5 (11) |
No surgery | 36 (85) |
SAPS 3 at ICU admission, median (IQR) | 74.0 58.8–84.0 |
Duration of CVVH therapy, median (IQR), hours | 215 (101–398) |
Pre-switch | 66 (38–156) |
Post-switch | 111 (45–335) |
Respiratory status during study period, no. (%) | |
Mechanical ventilation during whole study period | 20 (48) |
Mechanical ventilation intermittently during study period | 12 (29) |
No mechanical ventilation | 9 (21) |
Study participation, median (IQR), hours | 114 (84–144) |
ICU stay, median (IQR), days | 19 (10–29) |
Hospital stay, median (IQR), days | 40 (23–63) |
Mortality, no./total no. (%) | |
ICU | 12/42 (28.6) |
Hospital | 19/42 (45.2) |